As mentioned above, if TEX are already in circulation, much data suggests there could be significant lymphocyte dysfunction [161]; this would likely abrogate effects of local APC stimulation of TEX vaccination (e.g., comparing the prophylactic immune response vs. that in the pre-established tumor setting [90]). Here, TEX46 is linked to neoplasm.